Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-22

Clinical Trial Update: Role of Ginkgo Biloba Extract in IUGR [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ginkgo Biloba Extract for intrauterine growth restriction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: Assiut University | Conditions: Intrauterine Growth Restriction (IUGR) | Phase 2 | Status: COMPLETED